Tag: CBT > Cannabis DEA: Page 6

Cannabis Rescheduling

US Congressman Attempts to Sway DEA From Rescheduling Cannabis

Rep. Andy Harris claims the FDA’s eight-factor analysis on cannabis was “flawed,” leading to a “misguided” recommendation to reschedule.

February 2, 2024

Legislation and Regulation

12 US Senators Say Cannabis Should Be Descheduled, Demand Transparency From DEA

The dozen Democrats requested responses to six questions regarding the DEA’s rescheduling process.

January 30, 2024

Cannabis Retail Price

Rescheduling, Legalization Prospects Top CBT's Most-Read Articles in January

Here are Cannabis Business Times’ top 10 stories this month.

January 25, 2024

Cannabis Rescheduling

Colorado Attorney General Leads Multistate Effort to Support Cannabis Rescheduling

Attorney General Phil Weiser spearheaded a letter signed by 11 other state attorneys general to encourage the Drug Enforcement Administration to reclassify cannabis as a Schedule III drug under the Controlled Substances Act.

January 16, 2024

Cannabis Rescheduling

US Congressman Urges DEA to Expedite Rescheduling Cannabis

Rep. Steve Cohen of Tennessee wrote a letter to Administrator Anne Milgram pushing to initiate the rulemaking process “quickly.”

January 5, 2024

Cannabis Rescheduling

Industry Attorney Weighs in on Possible Cannabis Rescheduling Timeline: ‘It Normally Takes Years and Years for This to Get Done’

Despite the U.S. Drug Enforcement Administration’s recent response to a letter from Rep. Earl Blumenauer urging the agency to deschedule cannabis, Porter Wright Morris & Arthur’s Shane Pennington says it could be after the 2024 election before federal officials come to a decision on cannabis’s Schedule I status.

January 4, 2024

Florida

5 Cannabis Policy Reform Efforts to Watch in 2024

From the SAFER Banking Act to state-level reform, Akerman’s Jonathan Robbins outlines the legislation and potential policy changes on the horizon for the industry.

December 27, 2023

Cannabis Rescheduling

Former US Attorneys Urge Federal Officials to Reject Cannabis Rescheduling Recommendation

Eric Berlin, partner at Dentons, shares insight into some of the arguments the 29 former attorneys make against removing cannabis from Schedule I of the Controlled Substances Act.

December 21, 2023

Georgia

‘We Won’t Stop Working for Patient Access’: Georgia Regulators Weigh Options After Receiving DEA Warning About Pharmacies Dispensing Medical Cannabis

Georgia Access to Medical Cannabis Commission members said during a Dec. 13 meeting that the DEA’s recent warning highlights conflicting federal and state cannabis policy and they plan to continue fighting for patient access.

December 14, 2023

Georgia

DEA Issues Warning to Georgia Pharmacies Dispensing Medical Cannabis

Pharmacies began dispensing medical cannabis to patients in October under Georgia law, but the DEA warned them Nov. 27 that federal law prohibits them from doing so.

December 12, 2023

Colorado

6 Governors Push Biden to Reschedule Cannabis Before Year’s End

Head executives from Colorado, Illinois, Louisiana, Maryland, New Jersey and New York penned the letter to the White House.

December 6, 2023

Ohio

The Top 10: CBT's Most-Read Articles in November

Here's a recap and list of the stories readers engaged most with this month.

November 29, 2023